| Prev Close | 41.42 |
| Day Low/High | 40.94 / 41.57 |
| 52 Wk Low/High | 39.40 / 63.85 |
Nu Skin Enterprises, Inc. Class A (NUS)
41.07
NYSE
| Exchange | NYSE |
| Shares Outstanding | 50.13B |
| Market Cap | 2.08B |
| P/E Ratio | 19.67 |
| Div & Yield | N.A. (N.A) |
Latest News
The Market Awaits the Fed
I am expecting Jerome Powell to be just a touch more hawkish.
Keeping an Eye on Landec Results
As the trading day winds down, there is only one company reporting after the close -- health and wellness product name Landec Corp. . Consensus expectations are for EPS of $0.00 vs. $0.08 in the year-ago quarter. We recently added shares of GNC Hold...
China Drives Another Nail in the Coffins of GNC and Vitamin Shoppe
Stand-alone vitamin and supplement shops like GNC and Vitamin Shoppe shares will continue to fall in light of a Justice Department investigation.
Dietary Supplement Stocks Looking Queasy
At what price should shares of these companies be bought or sold?
4 Stocks That Are Fit for Fitness
These companies should feast as more obese Americans turn to exercise and healthy foods.
Day Ahead: Bond Selloff Still On
The yields are still being pushed higher.
Hits and Misses of 2014, Part 1
Did my portfolio pass muster?
Some Stocks to Watch Today
Though broad futures have improved somewhat. Market futures are still pointing to a down open, but they have improved somewhat since my first Diary post this morning. Meantime, oil just can't get any love. The International Energy Agency (IEA) has c...
Profit From the Longer Life Spans, Part 2
The trend is global, and the investment opportunities extend beyond health-care companies.
Hedge Funds Should Come Up Short
When will real short-selling come back into vogue?
The Week Ahead
Still plenty of earnings, but the econ calendar lightens up.
Day Ahead: FedEx Snowbound
Winter weather grounds shipper's results; futures on the rise.
Medifast Off to Fast Start Despite Nu Skin, Herbalife Hoopla
The start of diet season - January through April - looks bright for Medifast so far, says the company's CEO Michael MacDonald, as does Medifast's expansion plans into Canada.
My Best Ideas for (the Start of) 2014
Let's run through them.
Vitamins May Not Help Your Portfolio
As new research raises skepticism about supplements, you may want to take profits.
Off the Charts
Keep it light until a more compelling set-up presents itself.
Off the Charts
Given recent volatility, a cautious approach is best.
If Ackman Has You Smelling Blood
Should you wish to bet against the much-maligned hedge fund manager, here's a handy buy-and-sell list.
Nu Skin and Avon Under the Microscope
Deutsche Bank is pressing the issue. Break in: Nu Skin Enterprises (NUS) and Avon Products (AVP) are being pushed by Deustche Bank now.
